Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors
2008

Age Differences in Breast Cancer Pathways

Sample size: 411 publication 10 minutes Evidence: moderate

Author Information

Author(s): Anders Carey K., Acharya Chaitanya R., Hsu David S., Broadwater Gloria, Garman Katherine, Foekens John A., Zhang Yi, Wang Yixin, Marcom Kelly, Marks Jeffrey R., Mukherjee Sayan, Nevins Joseph R., Blackwell Kimberly L., Potti Anil

Primary Institution: Duke University

Hypothesis

To define the biology driving the aggressive nature of breast cancer arising in young women.

Conclusion

Breast cancer in young women shows distinct biological characteristics that could inform targeted treatment strategies.

Supporting Evidence

  • Young women with breast cancer have a higher probability of PI3K and Myc pathway deregulation.
  • Distinct patterns of oncogenic pathway deregulation were identified in young women compared to older women.
  • The study found that younger age at diagnosis is a significant predictor of poorer outcomes.

Takeaway

Young women with breast cancer have different tumor characteristics than older women, which can help doctors choose better treatments.

Methodology

The study analyzed gene expression data from 784 breast cancer patients, focusing on age-specific cohorts and oncogenic pathway deregulation.

Limitations

The study did not include patients aged 45-65 years, which may limit the generalizability of the findings.

Participant Demographics

Patients were divided into two age groups: young (≤45 years) and older (≥65 years).

Statistical Information

P-Value

p=0.006 for PI3K, p=0.03 for Myc

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001373

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication